Cd79atm1(cre)Reth/Cd79a+ Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu
involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL
|
abnormal B cell differentiation |
J:209928
|
abnormal B cell number |
J:209928
|
decreased pre-B cell number |
J:209928
|
increased pro-B cell number |
J:209928
|
normal
neoplasm |
J:209928
|
Ikzf1m1Btlr/Ikzf1m1Btlr
C57BL/6J-Ikzf1m1Btlr
|
abnormal natural killer cell mediated cytotoxicity |
J:265249
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number |
J:265249
|
decreased CD8-positive, naive alpha-beta T cell number |
J:265249
|
decreased heart rate |
J:265249
|
enhanced humoral immune response |
J:265249
|
increased B-1 B cell number |
J:265249
|
increased CD4-positive, alpha-beta T cell number |
J:265249
|
increased CD8-positive, alpha-beta T cell number |
J:265249
|
increased central memory CD4-positive, alpha-beta T cell number |
J:265249
|
increased central memory CD8 positive, alpha-beta T cell number |
J:265249
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:265249
|
increased IgG level |
J:265249
|
increased response to antigen |
J:265249
|
increased single-positive T cell number |
J:265249
|
increased T cell number |
J:265249
|
Ikzf1m2Btlr/Ikzf1m2Btlr
C57BL/6J-Ikzf1m2Btlr
|
decreased B cell number |
J:265250
|
decreased CD4-positive, alpha-beta T cell number |
J:265250
|
decreased CD8-positive, naive alpha-beta T cell number |
J:265250
|
decreased heart rate |
J:265250
|
decreased single-positive T cell number |
J:265250
|
decreased T cell number |
J:265250
|
increased CD8-positive, alpha-beta T cell number |
J:265250
|
increased central memory CD4-positive, alpha-beta T cell number |
J:265250
|
increased central memory CD8 positive, alpha-beta T cell number |
J:265250
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:265250
|
increased effector memory CD8-positive, alpha-beta T cell number |
J:265250
|
increased single-positive T cell number |
J:265250
|
Ikzf1m3Btlr/Ikzf1m3Btlr
C57BL/6J-Ikzf1m3Btlr
|
decreased CD4-positive, alpha-beta T cell number |
J:265251
|
increased B-1 B cell number |
J:265251
|
increased CD8-positive, alpha-beta T cell number |
J:265251
|
increased single-positive T cell number |
J:265251
|
increased T cell number |
J:265251
|
Ikzf1plstc/Ikzf1+
C57BL/6JSfdAnu-Ikzf1plstc
|
abnormal B cell differentiation |
J:84569
|
abnormal lymphopoiesis |
J:84569
|
abnormal T cell differentiation |
J:84569
|
decreased double-negative T cell number |
J:84569
|
decreased double-positive T cell number |
J:84569
|
decreased mature B cell number |
J:84569
|
decreased pre-B cell number |
J:84569
|
decreased thymocyte number |
J:84569
|
increased leukemia incidence |
J:84569
|
increased pro-B cell number |
J:84569
|
increased T cell derived lymphoma incidence |
J:84569
|
liver hypoplasia |
J:84569
|
myeloid hyperplasia |
J:84569
|
premature death |
J:84569
|
Ikzf1plstc/Ikzf1plstc
C57BL/6JSfdAnu-Ikzf1plstc
|
abnormal erythroblast morphology |
J:84569
|
abnormal granulocyte differentiation |
J:84569
|
abnormal lymphopoiesis |
J:84569
|
abnormal macrophage differentiation |
J:84569
|
abnormal myelopoiesis |
J:84569
|
absent pro-B cells |
J:84569
|
absent T cells |
J:84569
|
anemia |
J:84569
|
arrested B cell differentiation |
J:84569
|
decreased erythrocyte cell number |
J:84569
|
decreased erythroid progenitor cell number |
J:84569
|
decreased fetal derived definitive erythrocyte cell number |
J:84569
|
decreased granulocyte number |
J:84569
|
decreased hematocrit |
J:84569
|
decreased hemoglobin content |
J:84569
|
increased macrophage cell number |
J:84569
|
lethality throughout fetal growth and development, complete penetrance |
J:84569
|
liver hypoplasia |
J:84569
|
pallor |
J:84569
|
reticulocytopenia |
J:84569
|
thymus hypoplasia |
J:84569
|
Ikzf1plstc/Ikzf1tm2Kge
involves: 129S4/SvJae * C57BL/6 * C57BL/6JSfdAnu
|
abnormal erythropoiesis |
J:84569
|
anemia |
J:84569
|
Ikzf1tm1.1Smale/Ikzf1tm1.1Smale
B6.Cg-Ikzf1tm1.1Smale
|
decreased B cell number |
J:208211
|
decreased B-1a cell number |
J:208211
|
decreased B-1b cell number |
J:208211
|
decreased DN1 thymic pro-T cell number |
J:208211
|
decreased immature B cell number |
J:208211
|
decreased mature B cell number |
J:208211
|
decreased pre-B cell number |
J:208211
|
normal
immune system phenotype |
J:208211
|
normal
neoplasm |
J:208211
|
thymus hypoplasia |
J:208211
|
Ikzf1tm1.1Smale/Ikzf1tm2Kge
involves: 129S4/SvJae * C57BL/6
|
lethality, complete penetrance |
J:208211
|
Ikzf1tm1Kast/Ikzf1tm1Kast
involves: 129S2/SvPas
|
abnormal B cell activation |
J:82813
|
abnormal B cell differentiation |
J:82813
|
decreased B cell number |
J:82813
|
decreased B cell proliferation |
J:82813
|
decreased B-1a cell number |
J:82813
|
decreased B-1b cell number |
J:82813
|
decreased IgG3 level |
J:82813
|
decreased spleen germinal center number |
J:82813
|
Ikzf1tm1Kge/Ikzf1+
involves: 129S4/SvJae * BALB/c
|
abnormal lymph node cortex morphology |
J:29355
|
abnormal lymph node medulla morphology |
J:29355
|
abnormal T cell differentiation |
J:29355
|
abnormal thymocyte activation |
J:29355
|
abnormal thymus lobule morphology |
J:29355
|
abnormal thymus medulla morphology |
J:29355
|
decreased spleen red pulp amount |
J:29355
|
enlarged cervical lymph nodes |
J:29355
|
enlarged mesenteric lymph nodes |
J:29355
|
enlarged thymus |
J:29355
|
increased leukemia incidence |
J:29355
|
increased spleen white pulp amount |
J:29355
|
increased T cell proliferation |
J:29355
|
lymph node hyperplasia |
J:29355
|
premature death |
J:29355
|
spleen hyperplasia |
J:29355
|
thymus cortex hypoplasia |
J:29355
|
Ikzf1tm1Kge/Ikzf1+
involves: 129S4/SvJae * C57BL/6
|
abnormal lymph node cortex morphology |
J:29355
|
abnormal lymph node medulla morphology |
J:29355
|
abnormal T cell differentiation |
J:29355
|
abnormal thymocyte activation |
J:29355
|
abnormal thymus lobule morphology |
J:29355
|
abnormal thymus medulla morphology |
J:29355
|
decreased spleen red pulp amount |
J:29355
|
enlarged cervical lymph nodes |
J:29355
|
enlarged mesenteric lymph nodes |
J:29355
|
enlarged thymus |
J:29355
|
increased leukemia incidence |
J:29355
|
increased spleen white pulp amount |
J:29355
|
increased T cell proliferation |
J:29355
|
lymph node hyperplasia |
J:29355
|
premature death |
J:29355
|
spleen hyperplasia |
J:29355
|
thymus cortex hypoplasia |
J:29355
|
Ikzf1tm1Kge/Ikzf1tm1Kge
involves: 129S4/SvJae * BALB/c
|
abnormal common myeloid progenitor cell morphology |
J:20671
|
abnormal definitive hematopoiesis |
J:20671
|
abnormal eosinophil morphology |
J:20671
|
abnormal erythroid progenitor cell morphology |
J:20671
|
abnormal gut flora balance |
J:20671
|
abnormal immune system organ morphology |
J:20671
|
abnormal NK cell morphology |
J:20671
|
abnormal spleen morphology |
J:20671
|
abnormal thymus cortex morphology |
J:20671
|
abnormal thymus morphology |
J:20671
|
absent axillary lymph nodes |
J:20671
|
absent B cells |
J:20671
|
absent cervical lymph nodes |
J:20671
|
absent inguinal lymph nodes |
J:20671
|
absent mesenteric lymph nodes |
J:20671
|
absent Peyer's patches |
J:20671
|
absent pre-B cells |
J:20671
|
arrested T cell differentiation |
J:20671
|
decreased body size |
J:20671
|
decreased bone marrow cell number |
J:20671
|
decreased gamma-delta intraepithelial T cell number |
J:20671
|
enlarged spleen |
J:20671
|
extramedullary hematopoiesis |
J:20671
|
increased basophil cell number |
J:20671
|
increased nucleated erythrocyte cell number |
J:20671
|
increased susceptibility to bacterial infection |
J:20671
|
intermingled spleen red and white pulp |
J:20671
|
lung inflammation |
J:20671
|
multifocal hepatic necrosis |
J:20671
|
postnatal lethality, incomplete penetrance |
J:20671
|
thymus hypoplasia |
J:20671
|
Ikzf1tm1Kge/Ikzf1tm1Kge
involves: 129S4/SvJae * C57BL/6
|
abnormal common myeloid progenitor cell morphology |
J:20671
|
abnormal definitive hematopoiesis |
J:20671
|
abnormal eosinophil morphology |
J:20671
|
abnormal erythroid progenitor cell morphology |
J:20671
|
abnormal gut flora balance |
J:20671
|
abnormal immune system organ morphology |
J:20671
|
abnormal NK cell morphology |
J:20671
|
abnormal spleen morphology |
J:20671
|
abnormal thymus cortex morphology |
J:20671
|
abnormal thymus morphology |
J:20671
|
absent axillary lymph nodes |
J:20671
|
absent B cells |
J:20671
|
absent cervical lymph nodes |
J:20671
|
absent inguinal lymph nodes |
J:20671
|
absent mesenteric lymph nodes |
J:20671
|
absent Peyer's patches |
J:20671
|
absent pre-B cells |
J:20671
|
arrested T cell differentiation |
J:20671
|
decreased body size |
J:20671
|
decreased bone marrow cell number |
J:20671
|
decreased gamma-delta intraepithelial T cell number |
J:20671
|
enlarged spleen |
J:20671
|
extramedullary hematopoiesis |
J:20671
|
increased basophil cell number |
J:20671
|
increased nucleated erythrocyte cell number |
J:20671
|
increased susceptibility to bacterial infection |
J:20671
|
intermingled spleen red and white pulp |
J:20671
|
lung inflammation |
J:20671
|
multifocal hepatic necrosis |
J:20671
|
postnatal lethality, incomplete penetrance |
J:20671
|
thymus hypoplasia |
J:20671
|
Ikzf1tm2.1Smale/Ikzf1tm2.1Smale
B6.Cg-Ikzf1tm2.1Smale
|
abnormal definitive hematopoiesis |
J:208211
|
abnormal lymphopoiesis |
J:208211
|
abnormal peripheral lymph node morphology |
J:208211
|
abnormal T cell differentiation |
J:208211
|
absent inguinal lymph nodes |
J:208211
|
absent NK cells |
J:208211
|
absent Peyer's patches |
J:208211
|
decreased B cell number |
J:208211
|
decreased body size |
J:208211
|
decreased DN2 thymocyte number |
J:208211
|
decreased DN3 thymocyte number |
J:208211
|
decreased double-negative T cell number |
J:208211
|
decreased double-positive T cell number |
J:208211
|
decreased immature B cell number |
J:208211
|
decreased mature B cell number |
J:208211
|
decreased plasmacytoid dendritic cell number |
J:208211
|
decreased pre-pro B cell number |
J:208211
|
normal
immune system phenotype |
J:208211
|
increased gamma-delta T cell number |
J:208211
|
increased lymphoma incidence |
J:208211
|
increased pre-B cell number |
J:208211
|
premature death |
J:208211
|
thymus cortex hypoplasia |
J:208211
|
thymus hypoplasia |
J:208211
|
Ikzf1tm2Kge/Ikzf1tm2.1Smale
involves: 129S4/SvJae * C57BL/6
|
lethality, complete penetrance |
J:208211
|
Ikzf1tm2Kge/Ikzf1tm2Kge
involves: 129S4/SvJae
|
abnormal dendritic cell number |
J:37317
|
abnormal erythropoiesis |
J:37317
|
abnormal splenic cell ratio |
J:37317
|
abnormal T cell differentiation |
J:37317,
J:208211
|
abnormal thymus development |
J:37317
|
absent axillary lymph nodes |
J:37317
|
absent B cells |
J:37317,
J:208211
|
absent B-1a cells |
J:37317
|
absent cervical lymph nodes |
J:37317
|
absent inguinal lymph nodes |
J:37317
|
absent mesenteric lymph nodes |
J:37317
|
absent NK cells |
J:37317,
J:208211
|
absent Peyer's patches |
J:37317
|
absent pre-B cells |
J:37317
|
absent pro-B cells |
J:37317
|
decreased double-positive T cell number |
J:37317
|
decreased gamma-delta intraepithelial T cell number |
J:37317
|
decreased granulocyte number |
J:37317
|
decreased mature gamma-delta T cell number |
J:37317
|
decreased plasmacytoid dendritic cell number |
J:208211
|
decreased splenocyte number |
J:37317
|
increased T cell proliferation |
J:37317
|
thymus hypoplasia |
J:37317
|
Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu Il7rtm1.1(icre)Hrr/Il7r+
involves: 129P2/OlaHsd * C57BL/6 * SJL
|
increased T cell derived lymphoma incidence |
J:209928
|
Ikzf1tm3Kge/Ikzf1tm3Kge Tg(CD2-icre)4Kio/?
involves: C57BL/10 * CBA/Ca
|
abnormal B cell physiology |
J:209927
|
increased T cell derived lymphoma incidence |
J:209927
|
Ikzf1tm3Kge/Ikzf1tm3Kge Tg(CD19-cre/ERT2)1Cgn/?
Not Specified
|
abnormal B cell apoptosis |
J:209927
|
absent pre-B cells |
J:209927
|
decreased pre-B cell number |
J:209927
|